NCT07281326 2025-12-15
A Study of AK138D1 in Advanced Malignant Tumors
Akeso
Phase 1 Recruiting
Clinical Trials
3 trialsNCT06730386 2025-03-06
A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors
Akeso
Phase 1 Recruiting
NCT06697665 2024-11-20
An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Recruiting